Institution
University of Jena
Education•Jena, Thüringen, Germany•
About: University of Jena is a education organization based out in Jena, Thüringen, Germany. It is known for research contribution in the topics: Laser & Population. The organization has 22198 authors who have published 45159 publications receiving 1401514 citations. The organization is also known as: Friedrich-Schiller-Universität Jena & Friedrich Schiller University Jena.
Topics: Laser, Population, Fiber laser, Femtosecond, Raman spectroscopy
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, the authors present a lecture course intended to fill the gap between graduate courses on quantum field theory and specialized reviews or forefront-research articles on functional renormalization group approaches to quantum fields and gauge theories.
Abstract: This lecture course is intended to fill the gap between graduate courses on quantum field theory and specialized reviews or forefront-research articles on functional renormalization group approaches to quantum field theory and gauge theories.
450 citations
••
TL;DR: This project will aid the identification and quantification of properties and mutual effects of antioxidants, bring a more rational basis to the classification of antioxidant assays with their constraints and challenges, and make the results more comparable and understandable.
Abstract: The chemical diversity of natural antioxidants (AOXs) makes it difficult to sepa- rate, detect, and quantify individual antioxidants from a complex food/biological matrix. Moreover, the total antioxidant power is often more meaningful to evaluate health beneficial effects because of the cooperative action of individual antioxidant species. Currently, there is no single antioxidant assay for food labeling because of the lack of standard quantification methods. Antioxidant assays may be broadly classified as the electron transfer (ET)- and hydrogen atom transfer (HAT)-based assays. The results obtained are hardly comparable because of the different mechanisms, redox potentials, pH and solvent dependencies, etc. of various assays. This project will aid the identification and quantification of properties and mutual effects of antioxidants, bring a more rational basis to the classification of antioxidant assays with their constraints and challenges, and make the results more comparable and understandable. In this regard, the task group members convey their own experiences in var- ious methods of antioxidants measurement.
450 citations
••
TL;DR: Results confirm that prejudice changes systematically with age during childhood but that no developmental trend is found in adolescence, indicating the stronger influence of the social context on prejudice with increasing age.
Abstract: This meta-analysis summarizes 113 research reports worldwide (121 cross-sectional and 7 longitudinal studies) on age differences in ethnic, racial, or national prejudice among children and adolescents. Overall, results indicated a peak in prejudice in middle childhood (5-7 years) followed by a slight decrease until late childhood (8-10 years). In addition to differences for the various operationalizations of prejudice, detailed findings revealed different age-related changes in prejudice toward higher versus lower status out-groups and positive effects of contact opportunities with the out-group on prejudice development. Results confirm that prejudice changes systematically with age during childhood but that no developmental trend is found in adolescence, indicating the stronger influence of the social context on prejudice with increasing age.
450 citations
••
TL;DR: It is shown that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance and is a pivotal regulator of fetom maternal tolerance that has potential therapeutic implications in threatened pregnancies.
Abstract: A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1–deficient (Lgals1−/−) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)–secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.
449 citations
••
Max Planck Society1, University of Cologne2, ASTRON3, University of Melbourne4, University of Göttingen5, Vanderbilt University6, Massachusetts Institute of Technology7, University of North Carolina at Chapel Hill8, VU University Amsterdam9, Memorial Sloan Kettering Cancer Center10, University of Bonn11, University of Zurich12, University of Oslo13, Heidelberg University14, University of Jena15, Drug Abuse Resistance Education16, Praxis17, French Institute of Health and Medical Research18, University of Bologna19, University of Liverpool20, Institut Gustave Roussy21
TL;DR: Support is provided for broad implementation of genome-based diagnosis of lung cancer by demonstrating the correlation between lung tumor subtype and its predominant mutations, and the benefit of genetic testing and targeted therapy in these patients.
Abstract: We characterized genome alterations in 1255 clinically annotated lung tumors of all histological subgroups to identify genetically defined and clinically relevant subtypes. More than 55% of all cases had at least one oncogenic genome alteration potentially amenable to specific therapeutic intervention, including several personalized treatment approaches that are already in clinical evaluation. Marked differences in the pattern of genomic alterations existed between and within histological subtypes, thus challenging the original histomorphological diagnosis. Immunohistochemical studies confirmed many of these reassigned subtypes. The reassignment eliminated almost all cases of large cell carcinomas, some of which had therapeutically relevant alterations. Prospective testing of our genomics-based diagnostic algorithm in 5145 lung cancer patients enabled a genome-based diagnosis in 3863 (75%) patients, confirmed the feasibility of rational reassignments of large cell lung cancer, and led to improvement in overall survival in patients with EGFR-mutant or ALK-rearranged cancers. Thus, our findings provide support for broad implementation of genome-based diagnosis of lung cancer.
449 citations
Authors
Showing all 22435 results
Name | H-index | Papers | Citations |
---|---|---|---|
Cornelia M. van Duijn | 183 | 1030 | 146009 |
Veikko Salomaa | 162 | 843 | 135046 |
Andreas Pfeiffer | 149 | 1756 | 131080 |
Bernhard O. Palsson | 147 | 831 | 85051 |
Robert Huber | 139 | 671 | 73557 |
Joachim Heinrich | 136 | 1309 | 76887 |
Michael Schmitt | 134 | 2007 | 114667 |
Paul D.P. Pharoah | 130 | 794 | 71338 |
David Robertson | 127 | 1106 | 67914 |
Yuri S. Kivshar | 126 | 1845 | 79415 |
Ulrich S. Schubert | 122 | 2229 | 85604 |
Andreas Hochhaus | 117 | 923 | 68685 |
Werner Seeger | 114 | 1113 | 57464 |
Th. Henning | 110 | 1036 | 44699 |
Sascha Husa | 107 | 362 | 69907 |